Document text
Principal Investigator: Arif Yurdagul
Organization: LOUISIANA STATE UNIV HSC SHREVEPORT
Fiscal Year: 2023
Award: $249,000
Funding agency: National Heart Lung and Blood Institute
Atherosclerotic cardiovascular disease (CVD) is the leading cause of death in the industrialized world. Most atherosclerotic plaques are clinically silent; however, a subset can lead to myocardial infarction, stroke, or sudden death. Atheromas that are linked to clinical events are characterized by large necrotic cores, which result from the defective clearance of apoptotic cells (ACs). When functioning normally, clearance of ACs, termed “efferocytosis”, resolves inflammation. Therefore, enhancing efferocytosis in advanced lesions may stabilize rupture-prone plaques and reduce clinical events. While the mechanisms that lead to phagocytosis of one AC have been well-defined, individual macrophages (MΦs) must engulf many ACs, termed “continued efferocytosis”, in vivo. Accordingly, two critical, unanswered questions are (a) how do MΦs process the cargo derived from degrading an AC, and (b) what mechanisms are in place that cue MΦs that have previously ingested an AC to internalize a subsequent AC.
Therefore, the overall objective of this proposal is to understand the signaling and metabolic pathways that enable the continued clearance of ACs and to harness these pathways towards a novel treatment strategy. This proposal tests two new pathways critical for continued efferocytosis. In the first pathway, MΦs metabolize AC-derived arginine into putrescine, through the sequential action of arginase 1 (Arg1) and ornithine decarboxylase (ODC), to remodel the actin cytoskeleton. In the second pathway, MΦs respond to the overabundance of AC-derived nutrients by stimulating the
nutrient sensor mTORC1 to recycle vesicles to the cell surface and supply the developing phagosome with plasma membrane. Aim 1 will explore the hypothesis that AC-derived arginine is metabolized into putrescine and examine the mechanisms by which putrescine regulates cytoskeletal remodeling. Aim 2 will test the hypothesis and investigate the mechanisms therein, that the putrescine-synthesizing enzymes Arg1 and ODC drive atherosclerosis regression and inflammation resolution. Aim 3 will explore the hypothesis that SLC38A9 senses AC-derived arginine and cholesterol to activate mTORC1 and identify the mechanisms that drive the internalization of a second AC. Successful completion of these aims will provide new mechanistic insight in how MΦs sense and metabolize the cargo from ingested ACs, which will provide new therapeutic opportunities to curb cardiovascular disease.
Terms: <1,4-Butanediamine><1,4-Diaminobutane><Actins><Affect><Apoplexy><Apoptotic><Area><Arginine><Arterial Fatty Streak><Arterial Fatty Streaks><Atheroma><Atheromatous><Atheromatous degeneration><Atheromatous plaque><Atheroscleroses><Atherosclerosis><Atherosclerotic Cardiovascular Disease><Award><Brain Vascular Accident><Business-Friendly Atmosphere><CSIF><CSIF-10><Cardiac infarction><Cardiovascular><Cardiovascular Body System><Cardiovascular Diseases><Cardiovascular Organ System><Cardiovascular system><Cause of Death><Cell Body><Cell membrane><Cell surface><Cells><Cellular Matrix><Cellular Metabolic Process><Cerebral Stroke><Cerebrovascular Apoplexy><Cerebrovascular Stroke><Cholesterol><Clinical><Critical Paths><Critical Pathways><Cues><Cytokine Synthesis Inhibitory Factor><Cytoplasmic Membrane><Cytoskeletal System><Cytoskeleton><Data><Enzyme Gene><Enzymes><Event><Funding><Future><Goals><Heart Vascular><Hepatic Proliferation Inhibitor><IL-10><IL10><IL10A><Individual><Industrialization><Inflammation><Ingestion><Interleukin 10 Precursor><Interleukin-10><L arginine amidinohydrolase><L-Arginine><L-Ornithine carboxy-lyase><Lesion><Link><Liver Immunoregulatory Protein><Liver-Derived Inhibitory Protein><Macrophage><Membrane><Mentors><Metabolic Pathway><Mice><Mice Mammals><Modeling><Murine><Mus><Myocardial Infarct><Myocardial Infarction><Mφ><Necrosis><Necrotic><Nutrient><Ornithine Carboxy-lyase><Ornithine Decarboxylase><Pathway interactions><Phagocytosis><Phagosomes><Phase><Plasma Membrane><Process><Publishing><Putrescine><RNA Seq><RNA sequencing><RNAseq><Recycling><Research><Resolution><Role><Rupture><Signal Pathway><Stroke><Sudden Death><Testing><Tetramethylenediamine><Vesicle><Work><arginase><arginine amidinase><atheromatosis><atherosclerosis plaque><atherosclerotic disease><atherosclerotic lesions><atherosclerotic plaque><atherosclerotic vascular disease><brain attack><business-friendly environment><canavanase><cardiac infarct><cardiovascular disorder><cell metabolism><cellular metabaolism><cerebral vascular accident><cerebrovascular accident><circulatory system><clinical relevance><clinically relevant><collaborative atmosphere><collaborative environment><coronary attack><coronary infarct><coronary infarction><cytokine><detection of nutrient><heart attack><heart infarct><heart infarction><in vivo><ingest><insight><interactive atmosphere><interactive environment><interdisciplinary atmosphere><interdisciplinary environment><intracellular skeleton><lipid mediator><membrane structure><nano particle><nano-sized particle><nanoparticle><nanosized particle><new approaches><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel><novel approaches><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel strategies><novel strategy><novel therapeutics><novel therapy><nutrient sensing><pathway><peer-group atmosphere><peer-group environment><perception of nutrients><plasmalemma><programs><resolutions><sensor><social role><stroked><strokes><trafficking><transcriptome sequencing><transcriptomic sequencing><treatment strategy><vulnerable plaque>